OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Benefits of weight loss of 10% or more in patients with overweight or obesity: A review
Abd A. Tahrani, John M. Morton
Obesity (2022) Vol. 30, Iss. 4, pp. 802-840
Closed Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Does Losing Weight Lower the Risk of Cancer: A Systematic Review and Meta-analysis
Nikolaos Tzenios, Mary Tazanios, Omasyarifa Binti Jamal Poh, et al.
(2022)
Open Access | Times Cited: 162

What is the pipeline for future medications for obesity?
Eka Melson, Uzma Ashraf, Dimitris Papamargaritis, et al.
International Journal of Obesity (2024)
Open Access | Times Cited: 112

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 97

The Interplay between Obesity and Inflammation
Ilinca Săvulescu-Fiedler, R. Mihalcea, Şerban Dragosloveanu, et al.
Life (2024) Vol. 14, Iss. 7, pp. 856-856
Open Access | Times Cited: 26

One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2433326-e2433326
Open Access | Times Cited: 16

Proteomic changes upon treatment with semaglutide in individuals with obesity
Lasse Maretty, Dipender Gill, Lotte Simonsen, et al.
Nature Medicine (2025)
Open Access | Times Cited: 4

New therapies for obesity
Dimitris Papamargaritis, Carel W. le Roux, Jens J. Holst, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 18, pp. 2825-2842
Open Access | Times Cited: 42

Primary care providers’ perceived barriers to obesity treatment and opportunities for improvement: A mixed methods study
Lauren Oshman, Amal Othman, Wendy Furst, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284474-e0284474
Open Access | Times Cited: 23

Approach to Obesity Treatment in Primary Care
Susan Z. Yanovski, Jack A. Yanovski
JAMA Internal Medicine (2024) Vol. 184, Iss. 7, pp. 818-818
Closed Access | Times Cited: 14

Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations
Ariana M. Chao, Jena Shaw Tronieri, Anastassia Amaro, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 4449-4461
Open Access | Times Cited: 38

Body composition and cancer survival: a narrative review
Patrick T. Bradshaw
British Journal of Cancer (2023) Vol. 130, Iss. 2, pp. 176-183
Open Access | Times Cited: 22

Future therapies for obesity
Eka Melson, Alexander D. Miras, Dimitris Papamargaritis
Clinical Medicine (2023) Vol. 23, Iss. 4, pp. 337-346
Open Access | Times Cited: 20

Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?
Prathima Gogineni, Eka Melson, Dimitris Papamargaritis, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 801-818
Open Access | Times Cited: 8

Obesity pharmacotherapy in older adults: a narrative review of evidence
Alex E. Henney, John Wilding, Uazman Alam, et al.
International Journal of Obesity (2024)
Open Access | Times Cited: 7

An Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond the 5% Weight Loss Goal
Connor Enright, Elizabeth A. Thomas, David Saxon
Journal of the Endocrine Society (2023) Vol. 7, Iss. 3
Open Access | Times Cited: 13

Diet Overall and Hypocaloric Diets Are Associated With Improvements in Depression but Not Anxiety in People With Metabolic Conditions: A Systematic Review and Meta-Analysis
Tonya Paris, Robin M. Daly, Gavin Abbott, et al.
Advances in Nutrition (2024) Vol. 15, Iss. 2, pp. 100169-100169
Open Access | Times Cited: 5

Glucagon‐like peptide‐1 receptor agonists to expand the healthy lifespan: Current and future potentials
Frederik Flindt Kreiner, Bernt Johan von Scholten, Peter Kurtzhals, et al.
Aging Cell (2023) Vol. 22, Iss. 5
Open Access | Times Cited: 13

Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomized controlled trial
Dimitris Papamargaritis, Werd Al‐Najim, Jonathan Lim, et al.
The Lancet Regional Health - Europe (2024) Vol. 39, pp. 100853-100853
Open Access | Times Cited: 4

Assessment of the Potential Clinical and Economic Impact of Weight Loss in the Adult Population with Obesity and Associated Comorbidities in Spain
María D. Ballesteros‐Pomar, Ened Rodríguez-Urgellés, Miquel Sastre-Belío, et al.
Advances in Therapy (2025) Vol. 42, Iss. 2, pp. 1265-1282
Open Access

The Goldilocks for chronic weight management—Balancing quantity with quality of weight loss
Kim Henriksen, Manu V. Chakravarthy, Cecilie Liv Bager, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access

The relationship between bariatric surgery and risk of hip or knee replacement in severe osteoarthritis is obesity class-specific
Julien Paccou, Soxna F. K. Fall, Xavier Lenne, et al.
Surgery for Obesity and Related Diseases (2025)
Closed Access

Remission as an Emerging Therapeutic Target in Type 2 Diabetes in the Era of New Glucose-Lowering Agents: Benefits, Challenges, and Treatment Approaches
Dimitra Vasdeki, Theocharis Koufakis, Georgios Tsamos, et al.
Nutrients (2022) Vol. 14, Iss. 22, pp. 4801-4801
Open Access | Times Cited: 18

Page 1 - Next Page

Scroll to top